1. Home
  2. FCAP vs STXS Comparison

FCAP vs STXS Comparison

Compare FCAP & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Capital Inc.

FCAP

First Capital Inc.

N/A

Current Price

$66.14

Market Cap

206.8M

Sector

Finance

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.78

Market Cap

190.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCAP
STXS
Founded
1891
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.8M
190.6M
IPO Year
1998
2004

Fundamental Metrics

Financial Performance
Metric
FCAP
STXS
Price
$66.14
$1.78
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
2.7K
367.0K
Earning Date
04-24-2026
05-12-2026
Dividend Yield
2.32%
N/A
EPS Growth
36.97
16.67
EPS
1.30
N/A
Revenue
$7,170,000.00
$29,346,617.00
Revenue This Year
N/A
$28.22
Revenue Next Year
N/A
$30.47
P/E Ratio
$48.20
N/A
Revenue Growth
1.57
N/A
52 Week Low
$33.88
$1.70
52 Week High
$71.00
$3.59

Technical Indicators

Market Signals
Indicator
FCAP
STXS
Relative Strength Index (RSI) 74.43 42.04
Support Level $50.24 $1.73
Resistance Level $71.00 $1.99
Average True Range (ATR) 1.91 0.10
MACD 0.80 -0.01
Stochastic Oscillator 95.70 21.25

Price Performance

Historical Comparison
FCAP
STXS

About FCAP First Capital Inc.

First Capital Inc is an Indiana chartered commercial bank that provides a variety of banking services to individuals and businesses. It provides retail and business banking, residential mortgage lending, real estate finance, and asset-based lending. The bank's primary source of revenue is real estate mortgage loans.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: